Roche Holding AG (LON:0TDF)
38.41
-1.09 (-2.76%)
At close: Aug 6, 2025
Ligand Pharmaceuticals Market Cap
Roche Holding AG has a market cap or net worth of 198.21 billion as of August 7, 2025. Its market cap has increased by 1.34% in one year.
Market Cap
198.21B
Enterprise Value
223.28B
Revenue
58.27B
Ranking
n/a
PE Ratio
22.90
Stock Price
$38.41
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 4.69B to 198.21B, an increase of 4,127.23%. That is a compound annual growth rate of 11.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 6, 2025 | 198.21B | 9.64% |
Dec 30, 2024 | 180.78B | -1.61% |
Dec 29, 2023 | 183.74B | -14.64% |
Dec 30, 2022 | 215.25B | -13.44% |
Dec 30, 2021 | 248.67B | 13.05% |
Dec 30, 2020 | 219.96B | 4.47% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 172.68B |
HSBC Holdings | 160.27B |
Shell | 157.58B |
Unilever | 112.01B |
Rolls-Royce Holdings | 91.69B |
British American Tobacco p.l.c. | 91.44B |
Rio Tinto Group | 76.42B |
RELX PLC | 71.41B |